Bellevue Group Portfolio holdings

AUM $4.46B

AUM

$4.46B

AUM Growth

-$732M (-14%)

Cap. Flow

-$131M

Cap. Flow % of AUM

-2.94%

Top 10 Holdings %Top 10 Hldgs %

48.58%

Holding

170

New

Increased

Reduced

Closed

1	Vertex Pharmaceuticals VRTX	$36.1M
2	VRNA Verona Pharma VRNA	$32.2M
3	Intuitive Surgical ISRG	$19.1M
4	Boston Scientific BSX	$18.6M
5	Abbott ABT	$17.6M

#	Name	Market Value	Portfolio Weight	Shares or Principal	Shares Change %	Capital Flow
151	AUTL 151 Autolus Therapeutics AUTL $601M	$0	0%	0 -41,500	Closed	–
152	152 Blueprint Medicines BPMC $8.29B	$0	0%	0 -3,200	Closed	–
153	153 Charles River Laboratories CRL $7.56B	$0	0%	0 -50,327	Closed	–
154	154 Denali Therapeutics DNLI $2.07B	$0	0%	0 -15,700	Closed	–
155	155 Fate Therapeutics FATE $122M	$0	0%	0 -4,839,779	Closed	–
156	156 Alphabet (Google) Class C GOOG $2.15T	$0	0%	0 -6,000	Closed	–
157	157 Kiniksa Pharmaceuticals KNSA $2.04B	$0	0%	0 -8,100	Closed	–
158	158 Kura Oncology KURA $492M	$0	0%	0 -13,600	Closed	–
159	159 Nurix Therapeutics NRIX $942M	$0	0%	0 -8,000	Closed	–
160	160 Omnicell OMCL $1.35B	$0	0%	0 -94,740	Closed	–
161	161 Ultragenyx Pharmaceutical RARE $3.74B	$0	0%	0 -4,000	Closed	–
162	162 Roivant Sciences ROIV $7.3B	$0	0%	0 -24,000	Closed	–
163	163 Sage Therapeutics SAGE $574M	$0	0%	0 -4,460,693	Closed	–
164	164 Terns Pharmaceuticals TERN $349M	$0	0%	0 -1,061,753	Closed	–
165	165 Tandem Diabetes Care TNDM $1.08B	$0	0%	0 -782,456	Closed	–
166	166 Veracyte VCYT $2.06B	$0	0%	0 -3,600	Closed	–
167	167 Viking Therapeutics VKTX $3.09B	$0	0%	0 -12,939	Closed	–
168	168 Xenon Pharmaceuticals XENE $2.44B	$0	0%	0 -8,200	Closed	–
169	ACCD 169 DELISTED Accolade, Inc. Common Stock ACCD	$0	0%	0 -615,509	Closed	–
170	ITCI 170 DELISTED Intra-Cellular Therapies Inc. ITCI	$0	0%	0 -2,440,240	Closed	–